Merck has seen its fair value estimate edge higher to $104.27, up from $102.33, following recent updates to its growth outlook. Analysts cite an improved revenue growth expectation and a small uptick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback